{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:34:31Z","timestamp":1791988471201,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012579","name":"Natural Science Foundation of Qinghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bcp.2024.116275","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:04:04Z","timestamp":1715184244000},"page":"116275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Exploring the role of myeloperoxidase in the atherosclerotic process in hypoxic mice based on the MAPK signaling pathway"],"prefix":"10.1016","volume":"225","author":[{"given":"Jingxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-5562","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116275_b0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-6756-8_25","article-title":"Stem cell exosomes: Cell-freetherapy for organ repair","volume":"1553","author":"Khan","year":"2017","journal-title":"Methods Mol. Biol. Clifton NJ"},{"issue":"8 Suppl","key":"10.1016\/j.bcp.2024.116275_b0010","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2024.116275_b0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","article-title":"Acute coronary syndromes: The way forward from mechanisms to precision treatment","volume":"136","author":"Crea","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bcp.2024.116275_b0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jacc.2014.11.041","article-title":"The myth of the \u201cvulnerable plaque\u201d: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment","volume":"65","author":"Arbab-Zadeh","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0030","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/ATVBAHA.113.302642","article-title":"Has our understanding of calcification in human coronary atherosclerosis progressed?","volume":"34","author":"Otsuka","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116275_b0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/ATVBAHA.114.304000","article-title":"Recent highlights of ATVB: Calcification","volume":"34","author":"Virmani","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116275_b0040","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1111600109","article-title":"Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through Acyl-CoA synthetase 1","volume":"109","author":"Kanter","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bcp.2024.116275_b0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2004.10.016","article-title":"Inflammation may be a bridge connecting hypertension and atherosclerosis","volume":"64","author":"Li","year":"2005","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: A comprehensive review","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.bcp.2024.116275_b0055","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jacc.2010.01.050","article-title":"Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol","volume":"55","author":"Bayturan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116275_b0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11883-015-0510-0","article-title":"Potential contributions of intimal and plaque hypoxia to atherosclerosis","volume":"17","author":"Fong","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"issue":"33","key":"10.1016\/j.bcp.2024.116275_b0065","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/152308603764816569","article-title":"Selenium-dependent enzymes in endothelial cell function","volume":"5","author":"Brigelius-Floh\u00e9","year":"2003","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.bcp.2024.116275_b0075","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/blood-2002-04-1149","article-title":"Current molecular models for NADPH oxidase regulation by Rac GTPase","volume":"100","author":"Bokoch","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bcp.2024.116275_b0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1291\/hypres.28.837","article-title":"Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-Knockout mice","volume":"28","author":"Nakano","year":"2005","journal-title":"Hypertens. Res. off. J. Jpn. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.bcp.2024.116275_b0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116275_b0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7150\/ijms.78362","article-title":"Continuous hypobaric hypoxia may promote atherosclerosis progression in apolipoprotein E-Deficient mice","volume":"20","author":"Luo","year":"2023","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bcp.2024.116275_b0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0003-9861(62)90321-1","article-title":"Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization","volume":"96","author":"Schultz","year":"1962","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2024.116275_b0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2019.02.022","article-title":"Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease","volume":"493","author":"Ndrepepa","year":"2019","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116275_b0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.bcp.2024.116275_b0110","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1046\/j.1432-1327.2000.01498.x","article-title":"Immunohistochemical evidence for the myeloperoxidase\/H2O2\/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins","volume":"267","author":"Malle","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI8797","article-title":"Increased atherosclerosis in myeloperoxidase-deficient mice","volume":"107","author":"Brennan","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.bcp.2024.116275_b0120","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1161\/CIRCULATIONAHA.104.516278","article-title":"Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice","volume":"111","author":"McMillen","year":"2005","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.bcp.2024.116275_b0125","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1093\/eurheartj\/ehy501","article-title":"Targeting myeloperoxidase in inflammatory atherosclerosis","volume":"39","author":"Senders","year":"2018","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.bcp.2024.116275_b0130","doi-asserted-by":"crossref","first-page":"e0214150","DOI":"10.1371\/journal.pone.0214150","article-title":"Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition","volume":"14","author":"Roth Flach","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2024.116275_b0135","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.3390\/ijms19123761","article-title":"Role of P38 MAPK in atherosclerosis and aortic valve sclerosis","volume":"19","author":"Reustle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116275_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-phyto-082712-102314","article-title":"MAPK cascades in plant disease resistance signaling","volume":"51","author":"Meng","year":"2013","journal-title":"Annu. Rev. Phytopathol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1159\/000363026","article-title":"Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the P38 MAPK pathway","volume":"34","author":"Guo","year":"2014","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116275_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/562860","article-title":"Multimarker screening of oxidative stress in aging","volume":"2014","author":"Syslov\u00e1","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"Pt 9","key":"10.1016\/j.bcp.2024.116275_b0155","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: A PET study in Parkinson\u2019s disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain J. Neurol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116275_b0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/13543776.2020.1780210","article-title":"A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (Focus on Cardiovascular Diseases, 2013\u20132019)","volume":"30","author":"Soubhye","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/bcp.13855","article-title":"Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers","volume":"85","author":"Gan","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116275_b0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cts.12859","article-title":"Early clinical experience with AZD4831, a novel myeloperoxidase inhibitor, developed for patients with heart failure with preserved ejection fraction","volume":"14","author":"Nelander","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/dmd.115.067868","article-title":"Pharmacokinetics and disposition of the thiouracil derivative PF-06282999, an orally bioavailable, irreversible inactivator of myeloperoxidase enzyme, across animals and humans","volume":"44","author":"Dong","year":"2016","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"issue":"165","key":"10.1016\/j.bcp.2024.116275_b0180","doi-asserted-by":"crossref","first-page":"20190732","DOI":"10.1098\/rsif.2019.0732","article-title":"The role of oxygen transport in atherosclerosis and vascular disease","volume":"17","author":"Tarbell","year":"2020","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.bcp.2024.116275_b0185","doi-asserted-by":"crossref","first-page":"1438470","DOI":"10.1155\/2022\/1438470","article-title":"Intermittent hypoxia and atherosclerosis: From molecular mechanisms to the therapeutic treatment","volume":"2022","author":"Luo","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116275_b0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-022-09851-8","article-title":"Tissue oxygenation stabilizes neovessels and mitigates hemorrhages in human atherosclerosis-induced angiogenesis","volume":"26","author":"Aplin","year":"2023","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.bcp.2024.116275_b0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/obr.12034","article-title":"Energy balance and obesity: From pathophysiological mechanisms to new treatment strategies","volume":"14","author":"Kayser","year":"2013","journal-title":"Obes. Rev. off. J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.bcp.2024.116275_b0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphys.2019.00430","article-title":"Body composition and body weight changes at different altitude levels: A systematic review and meta-analysis","volume":"10","author":"D\u00fcnnwald","year":"2019","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116275_b0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/ham.2006.7.245","article-title":"Lipid profile, waist circumference, and body mass index in a high altitude population","volume":"7","author":"Mohanna","year":"2006","journal-title":"High Alt. Med. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116275_b0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/ham.2012.1071","article-title":"Changes in cardiovascular functions, lipid profile, and body composition at high altitude in two different ethnic groups","volume":"14","author":"Vats","year":"2013","journal-title":"High Alt. Med. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/ham.2007.8405","article-title":"Hematological and lipid profile changes in sea-level natives after exposure to 3550-m altitude for 8 months","volume":"8","author":"Siqu\u00e9s","year":"2007","journal-title":"High Alt. Med. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116275_b0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/ham.2007.8310","article-title":"Chronic intermittent hypoxia at high altitude exposure for over 12 years: Assessment of hematological, cardiovascular, and renal effects","volume":"8","author":"Brito","year":"2007","journal-title":"High Alt. Med. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116275_b0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116275_b0230","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1164\/rccm.200612-1771OC","article-title":"Chronic intermittent hypoxia induces atherosclerosis","volume":"175","author":"Savransky","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116275_b0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","article-title":"Atherosclerotic plaque destabilization: Mechanisms, models, and therapeutic strategies","volume":"114","author":"Silvestre-Roig","year":"2014","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2024.116275_b0240","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: New prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0245","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvab010","article-title":"NLRP3 inflammasome as a key driver of vascular disease","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116275_b0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice","volume":"4","author":"Akita","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.bcp.2024.116275_b0255","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2024.116275_b0260","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1021\/acsnano.6b01114","article-title":"Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis","volume":"10","author":"Kamaly","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2024.116275_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.03.037","article-title":"The other myeloperoxidase: Emerging functions","volume":"649","author":"Vanhamme","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"44","key":"10.1016\/j.bcp.2024.116275_b0270","doi-asserted-by":"crossref","first-page":"41279","DOI":"10.1074\/jbc.M106958200","article-title":"Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase","volume":"276","author":"Fu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116275_b0275","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/antiox11081616","article-title":"Activation and inhibition of human matrix metalloproteinase-9 (MMP9) by HOCl, myeloperoxidase and chloramines","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxid. Basel Switz."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/17534259221090679","article-title":"The effect of myeloperoxidase-oxidized LDL on THP-1 Macrophage polarization and repolarization","volume":"28","author":"Bazzi","year":"2022","journal-title":"Innate Immun."},{"issue":"5","key":"10.1016\/j.bcp.2024.116275_b0285","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1189\/jlb.0109012","article-title":"Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family","volume":"86","author":"Ehrenfeld","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116275_b0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001573-200109000-00006","article-title":"The thin-cap fibroatheroma: A type of vulnerable plaque: The major precursor lesion to acute coronary syndromes","volume":"16","author":"Kolodgie","year":"2001","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.bcp.2024.116275_b0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116275_b0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(99)00371-8","article-title":"Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery","volume":"150","author":"Pasterkamp","year":"2000","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bcp.2024.116275_b0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/86490","article-title":"Vascular endothelial growth factor enhances atherosclerotic plaque progression","volume":"7","author":"Celletti","year":"2001","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116275_b0310","doi-asserted-by":"crossref","first-page":"e0200499","DOI":"10.1371\/journal.pone.0200499","article-title":"7-ketocholesterol enhances leukocyte adhesion to endothelial cells via p38MAPK pathway","volume":"13","author":"Tani","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2024.116275_b0315","first-page":"5327","article-title":"Leptin upregulates smooth muscle cell expression of MMP-9 to promote plaque destabilization by activating AP-1 via the leptin receptor\/MAPK\/ERK signaling pathways","volume":"16","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"31","key":"10.1016\/j.bcp.2024.116275_b0320","doi-asserted-by":"crossref","first-page":"32205","DOI":"10.1074\/jbc.M402070200","article-title":"Extracellular oxidation by taurine chloramine activates ERK via the epidermal growth factor receptor","volume":"279","author":"Midwinter","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116275_b0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20100082","article-title":"The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages","volume":"430","author":"Lane","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116275_b0330","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fphys.2012.00214","article-title":"Fibrosis in atrial fibrillation - Role of reactive species and MPO","volume":"3","author":"Friedrichs","year":"2012","journal-title":"Front. Physiol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:38:20Z","timestamp":1718854700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":66,"alternative-id":["S0006295224002582"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116275","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of myeloperoxidase in the atherosclerotic process in hypoxic mice based on the MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116275"}}